These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 31030372)

  • 21. Dose-linearity of the pharmacokinetics of an intravenous [
    van Groen BD; Vaes WH; Park BK; Krekels EHJ; van Duijn E; Kõrgvee LT; Maruszak W; Grynkiewicz G; Garner RC; Knibbe CAJ; Tibboel D; de Wildt SN; Turner MA
    Br J Clin Pharmacol; 2019 Oct; 85(10):2332-2340. PubMed ID: 31269280
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of microdosing to predict pharmacokinetics at the therapeutic dose: experience with 5 drugs.
    Lappin G; Kuhnz W; Jochemsen R; Kneer J; Chaudhary A; Oosterhuis B; Drijfhout WJ; Rowland M; Garner RC
    Clin Pharmacol Ther; 2006 Sep; 80(3):203-15. PubMed ID: 16952487
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Impact of microdose clinical trials in the preclinical stage].
    Kim S
    Yakugaku Zasshi; 2014; 134(4):459-63. PubMed ID: 24694804
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Microdosing of protein drugs.
    Rowland M
    Clin Pharmacol Ther; 2016 Feb; 99(2):150-2. PubMed ID: 26452582
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Physiologically based predictions of the impact of inhibition of intestinal and hepatic metabolism on human pharmacokinetics of CYP3A substrates.
    Fenneteau F; Poulin P; Nekka F
    J Pharm Sci; 2010 Jan; 99(1):486-514. PubMed ID: 19479982
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Utility of a microdose study for drug discovery and development].
    Yamaura Y
    Nihon Yakurigaku Zasshi; 2013 Mar; 141(3):126-30. PubMed ID: 23470476
    [No Abstract]   [Full Text] [Related]  

  • 27. Pediatric microdose and microtracer studies using 14C in Europe.
    Turner MA; Mooij MG; Vaes WH; Windhorst AD; Hendrikse NH; Knibbe CA; Kõrgvee LT; Maruszak W; Grynkiewicz G; Garner RC; Tibboel D; Park BK; de Wildt SN
    Clin Pharmacol Ther; 2015 Sep; 98(3):234-7. PubMed ID: 26095095
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Microdosing clinical study: pharmacokinetic, pharmacogenomic (SLCO2B1), and interaction (grapefruit juice) profiles of celiprolol following the oral microdose and therapeutic dose.
    Ieiri I; Doi Y; Maeda K; Sasaki T; Kimura M; Hirota T; Chiyoda T; Miyagawa M; Irie S; Iwasaki K; Sugiyama Y
    J Clin Pharmacol; 2012 Jul; 52(7):1078-89. PubMed ID: 21593283
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of microdosing strategies for studies in preclinical drug development: demonstration of linear pharmacokinetics in dogs of a nucleoside analog over a 50-fold dose range.
    Sandhu P; Vogel JS; Rose MJ; Ubick EA; Brunner JE; Wallace MA; Adelsberger JK; Baker MP; Henderson PT; Pearson PG; Baillie TA
    Drug Metab Dispos; 2004 Nov; 32(11):1254-9. PubMed ID: 15286054
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of P-glycoprotein-mediated intestinal efflux kinetics on oral bioavailability of P-glycoprotein substrates.
    Kwon H; Lionberger RA; Yu LX
    Mol Pharm; 2004; 1(6):455-65. PubMed ID: 16028357
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetic and pharmacogenomic profiles of telmisartan after the oral microdose and therapeutic dose.
    Ieiri I; Nishimura C; Maeda K; Sasaki T; Kimura M; Chiyoda T; Hirota T; Irie S; Shimizu H; Noguchi T; Yoshida K; Sugiyama Y
    Pharmacogenet Genomics; 2011 Aug; 21(8):495-505. PubMed ID: 21691256
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interaction of Drug or Food with Drug Transporters in Intestine and Liver.
    Nakanishi T; Tamai I
    Curr Drug Metab; 2015; 16(9):753-64. PubMed ID: 26630906
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The application of Phase 0 and microtracer approaches in early clinical development: past, present, and future.
    Roffel AF; van Hoogdalem EJ
    Front Pharmacol; 2024; 15():1369079. PubMed ID: 38562464
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predicting human drug pharmacokinetics from in vitro permeability using an absorption-disposition model.
    Fliszar KA; Hill BT; Foster N
    J Pharm Sci; 2007 Aug; 96(8):2161-70. PubMed ID: 17387695
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Microdosing clinical study to clarify pharmacokinetic and pharmacogenetic characteristics of atorvastatin in Japanese hypercholesterolemic patients.
    Lee N; Maeda K; Fukizawa S; Ieiri I; Tomaru A; Akao H; Takeda K; Iwadare M; Niwa O; Masauji T; Yamane N; Kajinami K; Kusuhara H; Sugiyama Y
    Drug Metab Pharmacokinet; 2019 Dec; 34(6):387-395. PubMed ID: 31594719
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mechanistic pharmacokinetic modeling for the prediction of transporter-mediated disposition in humans from sandwich culture human hepatocyte data.
    Jones HM; Barton HA; Lai Y; Bi YA; Kimoto E; Kempshall S; Tate SC; El-Kattan A; Houston JB; Galetin A; Fenner KS
    Drug Metab Dispos; 2012 May; 40(5):1007-17. PubMed ID: 22344703
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ontogeny of oral drug absorption processes in children.
    Mooij MG; de Koning BA; Huijsman ML; de Wildt SN
    Expert Opin Drug Metab Toxicol; 2012 Oct; 8(10):1293-303. PubMed ID: 22686526
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A human microdose study of the antimalarial drug GSK3191607 in healthy volunteers.
    Okour M; Derimanov G; Barnett R; Fernandez E; Ferrer S; Gresham S; Hossain M; Gamo FJ; Koh G; Pereira A; Rolfe K; Wong D; Young G; Rami H; Haselden J
    Br J Clin Pharmacol; 2018 Mar; 84(3):482-489. PubMed ID: 29168205
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Validation of a microdose probe drug cocktail for clinical drug interaction assessments for drug transporters and CYP3A.
    Prueksaritanont T; Tatosian DA; Chu X; Railkar R; Evers R; Chavez-Eng C; Lutz R; Zeng W; Yabut J; Chan GH; Cai X; Latham AH; Hehman J; Stypinski D; Brejda J; Zhou C; Thornton B; Bateman KP; Fraser I; Stoch SA
    Clin Pharmacol Ther; 2017 Apr; 101(4):519-530. PubMed ID: 27943276
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A physiological view and structures of mean residence times.
    Durišová M
    Gen Physiol Biophys; 2014; 33(1):75-80. PubMed ID: 24334531
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.